Read a review of the current literature supporting health professionals in managing a vancomycin-resistant enterococci outbreak, which found six areas to consider.

Oral vancomycin is effective in achieving clinical and biochemical remission in paediatric patients with non-primary ...

Vancomycin, a glycopeptide antibiotic, is commonly used to treat gram-positive pathogens associated with vascular-access-related infections, such as coagulase negative Staphylococcus species ...

Fortunately it is still significantly vulnerable to vancomycin, which has been doctors’ first-line treatment against MRSA infections for 40 years.

Vancomycin flushing syndrome (VFS) is a reaction to the antibiotic drug vancomycin. Common symptoms consist of a rash that itches during or after the infusion of vancomycin. VFS is the most common ...

Reviews of Infectious Diseases, Vol. 3, Supplement. Reassessments of Vancomycin: A Potentially Useful Antibiotic (Nov. - Dec., 1981), pp. S224-S229 (6 pages) The 50% lethal dose (LD₅₀) of vancomycin ...

Despite vancomycin's performance against placebo, both options had relatively high CDI recurrence rates 8 weeks after treatment completion in 81 patients randomized to either prophylactic oral ...

We conducted a seven-month prospective study of 51 patients who were colonized with vancomycin-resistant enterococci, as evidenced by the presence of the bacteria in stool. We examined the density ...

Since the description in 2002 of the vanA gene cluster in MRSA as the mechanism of high-level vancomycin resistance, 13 isolates have been reported in the United States, 1,2 with others reported ...